India  

'Covishield' ready to roll out in coming weeks: Poonawalla

IndiaTimes Sunday, 3 January 2021
Serum Institute of India CEO Adar Poonawalla on Sunday said the Oxford-AstraZeneca Covid-19 vaccine 'Covishield' is ready to roll out in the coming weeks. Poonawalla's remarks came soon after after India's drugs regulator approved Covishield for restricted emergency use.
0
shares
ShareTweetSavePostSend
 

You Might Like


Related videos from verified sources

Fire has no impact on 'Covishield' vaccine production: Serum Institute of India [Video]

Fire has no impact on 'Covishield' vaccine production: Serum Institute of India

Serum Institute of India (SII) CEO Adar Poonawalla on January 22 informed that there is no impact of fire on the production of 'Covishield' vaccine. "The extent of the damage is more than 1,000 crores...

Credit: ANI     Duration: 01:16Published
Watch: SII CEO Poonawalla receives shot of Covishield vaccine [Video]

Watch: SII CEO Poonawalla receives shot of Covishield vaccine

Serum Institute of India (SII), CEO Adar Poonawalla received a COVISHIELD vaccine shot on January 16. COVISHIELD vaccine is manufactured by SII. India has approved 2 vaccines - Covishield and Covaxin...

Credit: ANI     Duration: 01:08Published
Release of first consignment of Covishield brings cheer to SII employees [Video]

Release of first consignment of Covishield brings cheer to SII employees

Employees and CEO-owner of Serum Institute of India (SII) Adar Poonawalla applauded at their office in Pune, as the first consignment of Covishield was dispatched across India on January 12.

Credit: ANI     Duration: 01:10Published

Related news from verified sources

Covishield COVID-19 vaccine ready to roll out in coming weeks: SII's Adar Poonawalla

Poonawalla's remarks came soon after DCGI approved Serum Institute's 'Covishield' vaccine for restricted emergency use in India.
DNA